Dramatic Response to Carboplatin plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis

Naohiro Oda, Masahiro Tabata, Masatoshi Uno, Yuzo Umeda, Hironari Kato, Toshio Kubo, Satoru Senoo, Takahito Yagi, Toshiyoshi Fujiwara, Yoshinobu Maeda, Katsuyuki Kiura

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Mucinous cystic neoplasm (MCN) of the pancreas is a rare cystic tumor occurring in the pancreatic body and tail in young to middle-aged women that is pathologically characterized by an ovarian-like stroma. Chemotherapy for recurrent/advanced pancreatic MCN has been based on chemotherapy regimens for pancreatic ductal adenocarcinoma, but the prognosis is poor. We herein report a 37-year-old woman with pancreatic mucinous cystadenocarcinoma with liver metastasis that responded dramatically to carboplatin plus paclitaxel therapy (CBDCA+PTX). CBDCA+PTX may be a treatment option for recurrent/advanced pancreatic MCN with an ovarian-like stroma.

Original languageEnglish
Pages (from-to)2967-2971
Number of pages5
JournalInternal Medicine
Volume60
Issue number18
DOIs
Publication statusPublished - 2021

Keywords

  • Carboplatin
  • Mucinous cystadenocarcinoma
  • Paclitaxel
  • Pancreas

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Dramatic Response to Carboplatin plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis'. Together they form a unique fingerprint.

Cite this